CSF2 and neoplasm: The DCs can present TAA to cytotoxic T cells to induce tumor-specific immunity while the oAd can co-express interleukin (IL)-12 and granulocyte-macrophage colony-stimulating factor (GM-CSF) to elicit synergistic tumor growth inhibition.